LUCY ORTEGA: Open Payments
NPI 1952490427 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 23 payments from 7 companies in 2025. Trend: 2023 $246 · 2024 $28 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $247 |
| Novo Nordisk Inc | 7 | $189 |
| Tandem Diabetes Care, Inc. | 2 | $43 |
| Ascendis Pharma Endocrinology Inc | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
Products named: EVENITY, Rybelsus, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Yorvipath, MOUNJARO, REPATHA, CRENESSITY.
Industry payments across OR — which companies pay providers there.
